Sudo Biosciences

Developer of therapeutics for immune-mediated inflammatory conditions

placeMenlo Park, California, United States calendar_todayFounded 2020 groups11 employees language sudobio.com

Registered entities

Social engagement

Social engagement: 2.7K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include TPG, The Rise Fund, Frazier Healthcare Partners, Leaps by Bayer.

Investor typeCountShare
Venture capital536%
Private equity536%
Other / undisclosed429%

Recent activity

18 Mar 2026
Leadership hire
Head of Translational Medicine
Coming soon